Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.

Carter, A M

Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus. [electronic resource] - Diabetic medicine : a journal of the British Diabetic Association Sep 2005 - 1282-4 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0742-3071

10.1111/j.1464-5491.2005.01632.x doi


C-Reactive Protein--analysis
Complement C3--analysis
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Humans
Hypoglycemic Agents--therapeutic use
Metformin--therapeutic use
Obesity--blood